THE USE OF POSITRON EMISSION TOMOGRAPHY (PET) IN THE STAGING/EVALUATION, TREATMENT, AND FOLLOW-UP OF PATIENTS WITH LUNG CANCER: A CRITICAL REVIEW

被引:44
作者
Mac Manus, Michael [1 ]
Hicks, Rodney J. [2 ,3 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic 3002, Australia
[2] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Vic 3002, Australia
[3] Univ Melbourne, Melbourne, Vic 3010, Australia
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 05期
关键词
Position emission tomography; Lung cancer; Radiation therapy; Surgery;
D O I
10.1016/j.ijrobp.2008.08.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[No abstract available]
引用
收藏
页码:1298 / 1306
页数:9
相关论文
共 59 条
[1]
An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer [J].
Akhurst, T ;
Downey, RJ ;
Ginsberg, MS ;
Gonen, M ;
Bains, M ;
Korst, R ;
Ginsberg, RJ ;
Rusch, VW ;
Larson, SM .
ANNALS OF THORACIC SURGERY, 2002, 73 (01) :259-264
[2]
Allen MS, 2003, ANN THORAC SURG, V75, P235
[3]
The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer [J].
Ashamalla, H ;
Rafla, S ;
Parikh, K ;
Mokhtar, B ;
Goswami, G ;
Kambam, S ;
Abdel-Dayem, H ;
Guirguis, A ;
Ross, P ;
Evola, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (04) :1016-1023
[4]
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) -: A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project [J].
Berghmans, Thierry ;
Dusart, Michele ;
Paesmans, Marianne ;
Hossein-Foucher, Claude ;
Buvat, Irene ;
Castaigne, Catherine ;
Scherpereel, Arnaud ;
Mascaux, Celine ;
Moreau, Michel ;
Roelandts, Martine ;
Alard, Stphane ;
Meert, Anne-Pascale ;
Patz, Edward F., Jr. ;
Lafitte, Jean-Jacques ;
Sculier, Jean-Paul .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :6-12
[5]
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer [J].
Bradley, J ;
Thorstad, WL ;
Mutic, S ;
Miller, TR ;
Dehdashti, F ;
Siegel, BA ;
Bosch, W ;
Bertrand, RJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01) :78-86
[6]
Bury T, 1999, EUR RESPIR J, V14, P1376
[7]
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT:: The impact of 18FDG-hybrid PET fusion [J].
Caldwell, CB ;
Mah, K ;
Ung, YC ;
Danjoux, CE ;
Balogh, JM ;
Ganguli, SN ;
Ehrlich, LE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :923-931
[8]
Cerfolio RJ, 2002, ANN THORAC SURG, V73, P401
[9]
Chen W, 2005, J NUCL MED, V46, P945
[10]
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG pet after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer [J].
Choi, NC ;
Fischman, AJ ;
Niemierko, A ;
Ryu, JS ;
Lynch, T ;
Wain, J ;
Wright, C ;
Fidias, P ;
Mathisen, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04) :1024-1035